On June 1, 2020, the Department of Justice (“DOJ”) issued an updated version of its “Evaluation of Corporate Compliance Programs” (the “DOJ Guidance”), available here. The DOJ Guidance is an update to ...
(This article was originally published on January 1, 2025. For a regularly updated version of this resource, see US Department of Justice Standards for Effective Corporate Compliance Programs on ...
In-house harmonization of excipient specifications ensures compliance with multiple pharmacopoeias, reducing redundant testing and aligning with global regulatory expectations. Specification ...
A failure to comply with applicable economic and trade sanctions and export controls can have significant legal, financial, and practical consequences for a company, including potential civil or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback